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approach would appear to have a logical basis if the 
recent work of Hall [4] with thyroid stimulators, 
demonstrating that T.S.I. (Thyroid Stimulating In- 
dex) [5] falls immediately postoperatively [6], with- 
stands further evaluations. This work provides the 
first clear evidence that surgery makes a definitive 
change in the function of the toxic thyroid gland 
remnant, Therefore, blood supply, or lack of it, may 
play an important role in the later development of 
hypothyroidism. 
I agree with the follow-up program outlined by 
Michie et al. Patients must be strongly encouraged to 
undertake their follow-up, even those taking thyroid 
hormone. They should have both clinical and labora- 
tory review, and thyrotrophin estimations should be 
part of the basic follow-up requirement. 
Hypothyroidism occurs for the reasons outlined 
and others yet to be revealed to future investigators. 
To do the best by our patients, in the current state of 
the art of surgery for hyperthyroidism, long-term 
follow-up is mandatory. This should include clinical 
and laboratory assessment and introduction of treat- 
ment when appropriate. This is the best insurance 
against hypothyroidism that can be provided at this 
time, as the authors suggest. 
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Michie and coworkers have done a very comprehen- 
sive study of the incidence and possible causes of 
hypothyroidism following subtotal thyroidectomy 
for thyrotoxicosis. Their impressive series of 554 
patients, acquired during a decade (1965-1974) in 
which radioactive iodine was widely used in treating 
adult patients with Graves' disease, contributes sig- 
nificantly to our knowledge about the end results of 
subtotal thyroidectomy. Their detailed follow-up, in- 
cluding both clinical and laboratory evaluation of 
thyroid function, in all of their patients is commenda- 
ble. Often, mild hypothyroidism is subclinical and 
not detected unless there is a specific search for 
evidence. 
The authors' concern that hypothyroidism may be 
a common problem following subtotal thyroidectomy 
is verified by recent reports showing an incidence 
ranging from 25 to 70%. Their study shows that the 
incidence of hypothyroidism is clearly related to the 
size of the thyroid remnant but may be influenced by 
the prevalence of thyroiditis and environmental fac- 
tors. The specific environmental factor they have 
identified as being significant is the iodine intake. 
They also emphasize that approximately 15% of pa- 
tients treated surgically will develop hypothyroidism 
regardless of technique and remnant size because of 
the natural history of the disease. 
The currently available evidence shows that the 2 
traditional goals of subtotal thyroidectomy for thyro- 
toxicosis, permanent cure and prevention of hypo- 
thyroidism, are mutually exclusive. It has been our 
opinion that the occurrence of hypothyroidism 
should not be considered a complication of an opera- 
tion done to cure thyrotoxicosis, but rather as re- 
cently stated by Utiger, "a  common consequence of 
effective surgical therapy" [ 1]. We consider the pri- 
mary goal of an operation for thyrotoxicosis to be the 
excision of sufficient thyroid tissue to alleviate the 
disease and prevent recurrence. Recurrent hyperthy- 
roidism, a more difficult problem to manage, is con- 
sidered a significant complication and a consequence 
of inadequate therapy. Definitive treatment of recur- 
rent thyrotoxicosis by reoperation is generally con- 
sidered hazardous, since such procedures are associ- 
ated with a complication rate estimated to be at least 
3 times that of a primary thyroid operation. The 
alternative is to recommend 1~I even though origi- 
nally considered unacceptable by the patient or re- 
ferring physician. Because of these factors, many 
surgeons accept a high incidence of hypothyroidism, 
providing that the incidence of recurrence is negligi- 
ble. The early recognition and appropriate timing of 
replacement therapy for those patients who develop 
permanent hypothyroidism, therefore, is of consider- 
able clinical importance. 
In a review of 285 thyroidectomies done at the 
University of Michigan for thyrotoxicosis between 
1950 and 1965, Olsen et al. found that 25% developed 
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hypothyroidism and 7% had recurrences when eval- 
uated [2]. In this series, 232 had Graves' disease, 
treated at a mean age of 24 years, and 53 patients had 
toxic nodular goiters treated at a mean age of 53 
years. The 13 patients (7%) developing recurrences 
did so from 3 to 9 years after operation (mean 5 
years). Fifty of the 200 patients followed for 2 or 
more years after a subtotal thyroidectomy developed 
hypothyroidism. The mean time at which this diag- 
nosis was established was 3 months after operation. 
Only 6 patients in the entire series developed hypo- 
thyroidism 6 months or more after operation and 
only 2 became hypothyroid (1%) after the first 2 
years. It was concluded that the critical time for 
establishing the diagnosis of hypothyroidism was by 
the sixth month (88%) in most patients, although 
continued follow-up studies were required after the 
second year to identify the rare patient with late 
onset of hypothyroidism and/or evidence of recur- 
rent hyperthyroidism. 
Because hypothyroidism is not entirely prevent- 
able after subtotal th.yroidectomy and attempts to do 
so result in an increased incidence of recurrence, 
some surgeons have advocated total thyroidectomy 
for the treatment of all patients with thyrotoxicosis. 
For example, Perzik [3] reported that there were no 
deaths or permanent recurrent laryngeal nerve inju- 
ries, and only 1 patient with permanent hypoparathy- 
roidism following this procedure in 326 patients with 
Graves' disease. There were, of course, no recur- 
rences. Additional benefits claimed were that no pa- 
tients developed or had progression of existing oph- 
thalmopathy and that the operations eliminated 
occult or microscopic papillary carcinomas found in 
7% of the patients. Exogenous thyroid hormone was 
given to all patients immediately after operation. The 
extremely low morbidity rate for total thyroidectomy 
reported by Perzik in the treatment of benign thyroid 
disease is unlikely to be equaled by any but very 
experienced thyroid surgical specialists. In an as- 
sessment of the over-all results of thyroid operations 
in the United States based upon the data from 24,108 
thyroid operations performed in 1970, Foster [4] 
showed that of those patients with toxic nodular 
goiters, 12% had total thyroidectomies with more 
frequent complications than the 88% having subtotal 
thyroidectomies. For patients with Graves' disease 
having total thyroidectomies (10%), the incidence of 
complications was not significantly different from 
those having subtotal thyroidectomies, with the ex- 
ception of recurrent laryngeal nerve injury which 
was 7 times more frequent. However, a 3% inci- 
dence of hypoparathyroidism following subtotal thy- 
roidectomy seems excessive. 
Currently, the majority of patients with thyrotoxi- 
cosis referred for surgical treatment at the University 
of Michigan are 25 years of age or younger. Most 
patients 35 years of age or older elect 131I therapy 
when offered the choice, although we continue to 
believe that subtotal thyroidectomy, unless contrain- 
dicated because of severe unrelated disease, is good 
treatment in older adults. We have not done total 
thyroidectomies for thyrotoxicosis in adult patients, 
although we have been leaving smaller remnants (4 g) 
in order to prevent recurrences. 
Recently, we have reevaluated our experience 
with children and adolescents treated surgically for 
Graves' disease during the period 1969-1976 [5]. In 
this group of 41 patients with a mean age of 13.3 
years, an effort was made to prevent recurrence 
rather than to prevent hypothyroidism. A remnant 
estimated to be no larger than 4 g was left in each 
patient. In many patients the remnant was believed 
to be only 2 g, and in 7, a total thyroidectomy was 
performed. The incidence of hypothyroidism in the 
group treated by subtotal thyroidectomy was 60%. 
Many of these children did not appear hypothyroid 
and would not have been detected without the bene- 
fit of biochemical studies which included serum thy- 
roxine, triiodothyronine, and thyrotropin (TSH) as- 
says. There was only 1 recurrence in this group, a 2- 
year-old child who developed a visible goiter 6 
months after subtotal thyroidectomy at which a thy- 
roid remnant of 4 g was left. In evaluating our total 
experience in 85 children having thyroidectomies for 
Graves' disease from 1945 through 1976, only 1 other 
patient, also under 10 years of age, developed recur- 
rence. Because none of the children older than 10 
years of age have developed recurrence and 40% are 
euthyroid without replacement therapy, we will con- 
tinue to do subtotal thyroidectomies, leaving a mini- 
mal remnant, in this age group. In those younger 
than 10 years of age, we have been doing either total 
or near-total thyroidectomies with the goal of elimi- 
nating recurrences altogether because of the need for 
either years of antithyroid drug therapy or use of 131I, 
neither of which is considered satisfactory treatment 
in this age group. We have had no difficulty in treat- 
ing hypothyroidism in the pediatric age group and 
patient compliance has not been a problem after 
hypothyroidism has been detected. Similar results in 
children having subtotal thyroidectomies for Graves' 
disease were recently reported by Wesley et al. [6]. 
They found that 25 of 43 children (58%) operated 
upon between 1964 and 1975 at the University of 
Southern California became hypothyroid, despite a 
mean remnant size of 4.3 g. Their only recurrence 
was in a 13-year-old girl who became symptomatic 6 
months after operation. They also were encouraged 
by the relative ease with which hypothyroidism can 
be treated by thyroid supplements. Consistent with a 
goal of curing hyperthyroidism, they concluded that 
the amount of gland left behind should be determined 
by the margin necessary to protect the integrity of 
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the parathyroid glands and the recurrent laryngeal 
nerves, and not on the amount to prevent postopera- 
tive hypothyroidism. 
From a practical clinical viewpoint, one of the 
most important aspects of the study of Michie et al. 
is the finding that the PBI levels at 1 and 4 months 
after operation were of value in predicting the ulti- 
mate outcome of  thyroid function. They found that 
when both values were low (< 4 txg%), all patients 
were permanently hypothyroid and required replace- 
ment therapy. Significantly, only 2 of their patients 
developed hypothyroidism more than a year after 
operation, confirming the impression that the late 
insidious development of  hypothyroidism following 
subtotal thyroidectomy is uncommon. We are in 
agreement with the authors in believing that the 
diagnosis of  permanent hypothyroidism can usually 
be made by the fourth month after operation. How- 
ever, a note of caution in this regard has been ex- 
pressed by Toft et al. [7] who found that 20% of their 
patients were temporarily hypothyroid when studied 
at 3 months. Only 14% showed evidence of  hypothy- 
roidism at 1 year, in contrast  to the 34% who would 
have been considered hypothyroid had not further 
studies been done at 6 months. Perhaps it would be 
best to wait for 6 months in an asymptomatic patient 
before making a final determination as to the need for 
permanent replacement therapy. 
Michie and his coworkers are commended for 
their continuing efforts to assure that patients treated 
surgically receive optimal care. Their continuing fol- 
low-up of  all patients subjected to thyroidectomy for 
thyrotoxicosis,  through a pioneering computer-as- 
sisted program, is a major contribution to the long- 
term management of these patients. 
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